新萊福(301323.SZ):關於輻射防護服類產品,目前公司在中東地區已與當地戰略協議客戶建立了穩定的合作關係
格隆匯6月18日丨新萊福(301323.SZ)在投資者互動平臺表示,關於輻射防護服類產品,目前公司在中東地區已與當地戰略協議客戶建立了穩定的合作關係。公司的柔性無鉛防護材料2023年全面上市後迅速打開市場,2024年銷售收入翻倍增長。全球範圍內,傳統鉛基材料仍佔主流,但公司是少數實現低成本無鉛材料規模化生產的企業,產品可與鉛基材料比成本,同時在環保性、輕量化與舒適性、定製化服務上更具優勢,目前公司在無鉛化趨勢下已佔據行業重要地位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.